Gland Pharma Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹1490 - ₹1500
- Lot size
- 10 shares
- Issue amount
- ₹6,479.55 cr
- Total subscription
- 0×
- Opens
- 9 Nov 2020
- Closes
- 11 Nov 2020
- Allotment
- 18 Nov 2020
- Listing
- 20 Nov 2020
Offer at a glance
Issue overview
- Issue size
- 4,31,96,968 shares
- Face value
- ₹1 per share
- Minimum investment
- ₹14,900
- Fresh issue
- ₹1,250 cr
- Offer for sale
- ₹5,229.55 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹15,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 15,49,49,490
- Shares after issue
- 16,32,82,823
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 10 | ₹15,000 |
| sHNI | 14 | 140 | ₹2,10,000 |
| bHNI | 67 | 670 | ₹10,05,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.
Strengths
- Wide range of complex injectable products.
- Diversified B2B model with a growing B2C presence in India.
- Advanced and scalable manufacturing capabilities.
- Strong financial performance and consistent growth.
- Led by an experienced and skilled management team.
Promoters
Fosun Pharma Industrial Pte. Ltd
Shanghai Fosun Pharmaceutical (Group) Co. Ltd
Registrar & documents
Lead manager
Citigroup Global Markets India Private Limited, Haitong Securities India Private Limited, Kotak Mahindra Capital Company Limited, Nomura Financial Advisory And Securities (India) Private Limited, Securities (India) Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
Sy. No. 143 - 148, 150 and 151, Near Gandi Maisamma 'X' Roads, D.P. Pally,Dundigal Medchal-Malkajgiri District, Hyderabad
+91 40 3051 0999
[email protected]Company website ↗Frequently Asked Questions
What is Gland Pharma IPO GMP today?
As of today, Gland Pharma IPO Grey Market Premium (GMP) is reported at +₹118 per share. Based on the upper price band of ₹1,500, the estimated listing price is ₹1,618 (+7.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Gland Pharma IPO?
The minimum bid lot size for Gland Pharma IPO is 10 shares. At the cut-off price of ₹1,500 per share, retail investors need a minimum application amount of ₹15,000 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Gland Pharma IPO allotment status be announced?
The allotment status for Gland Pharma IPO is scheduled to be finalized on 18 Nov 2020. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Gland Pharma IPO allotment status online by PAN?
To check Gland Pharma IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Gland Pharma Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.